6 Meridian’s Bristol-Myers Squibb BMY Stock Holding History

6 Meridian’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$5.3M	Sell	85,073 -496	-0.6%	-$29.1K	0.39%	47
2021 Q3	$5.06M	Buy	85,569 +82,289	+2,509%	+$5.42M	0.4%	48
2021 Q2	$219K	Sell	3,280 -110	-3%	-$7.17K	0.02%	326
2021 Q1	$214K	Buy	+3,390	New	+$211K	0.02%	337
2019 Q3	–	Sell	-282,968	Closed	-$12.8M	–	457
2019 Q2	$12.8M	Buy	282,968 +2,055	+0.7%	+$95.7K	1.29%	19
2019 Q1	$13.4M	Buy	280,913 +60,871	+28%	+$3.03M	1.35%	20
2018 Q4	$11.4M	Sell	220,042 -33,253	-13%	-$1.79M	1.31%	19
2018 Q3	$15.7M	Buy	253,295 +145,659	+135%	+$8.64M	1.61%	17
2018 Q2	$5.96M	Buy	107,636 +5,511	+5%	+$298K	0.63%	56
2018 Q1	$6.46M	Buy	+102,125	New	+$6.57M	0.72%	46

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

6 Meridian's BMY Position: Q4 2021 in Review

6 Meridian reduced its Bristol-Myers Squibb (BMY) stake by 0.58% in Q4 2021, selling an estimated $29.1K and leaving 85,073 shares worth $5.3M. The position accounts for 0.39% of the portfolio, ranked #47.

6 Meridian first reported a position in BMY in Q1 2018 and has held it in 10 quarters since. The position peaked at $15.7M in Q3 2018. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

6 Meridian held 85,073 shares of Bristol-Myers Squibb worth $5.3M as of Q4 2021.
6 Meridian sold 496 Bristol-Myers Squibb shares in Q4 2021, an estimated $29.1K.
Bristol-Myers Squibb made up 0.39% of 6 Meridian's portfolio in Q4 2021, its #47 holding.
6 Meridian first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 10 quarters since.
6 Meridian's Bristol-Myers Squibb position peaked at $15.7M in Q3 2018.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on 6 Meridian's 13F filing for Q4 2021, filed 1 Feb 2022.